GlassScriptPhysician profile
Ashley Bennett Bowen
NPI 1053581496
$31,574.48
in general payments reported to CMS, 2019-2025
44 companies · $1,711 in 2025
The $1,711 reported for 2025 was more than what 76% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,149 · 2020: $1,336 · 2021: $10K · 2022: $1,807 · 2023: $9,327 · 2024: $1,913 · 2025: $1,711.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,751 · Education: $4,000 · Travel and Lodging: $3,200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,750.56 |
| Education | $4,000.00 |
| Travel and Lodging | $3,200.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Uromedica, Incorporated | $9,970.69 | 2019-2022 | |
| Intuitive Surgical, INC. | $6,623.24 | 2020-2023 | Da Vinci Surgical System |
| Coloplast Corp | $4,229.35 | 2019-2025 | Speedicath |
| Boston Scientific Corporation | $3,547.34 | 2019-2025 | Ams 700, General - Erectile Dysfunction, Ams 700 Cxr Rte Kit |
| Procept Biorobotics Corporation | $1,717.34 | 2019-2025 | Aquabeam Robotic System, Aquabeam System |
| Astellas Pharma US INC | $708.30 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Medtronic, INC. | $551.83 | 2022-2025 | Interstim |
| Abbvie INC. | $529.12 | 2021-2025 | Lupron Depot, Botox |
| Pfizer INC. | $490.05 | 2021-2025 | |
| Axonics, INC. | $338.40 | 2021-2024 | Axonics, Bulkamid |
| Sumitomo Pharma America, INC. | $224.15 | 2023-2025 | Orgovyx, Gemtesa |
| Verity Pharmaceuticals INC. | $218.67 | 2024-2025 | Trelstar |
| Endo Pharmaceuticals INC. | $198.08 | 2019-2021 | |
| Allergan, INC. | $187.51 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $145.49 | 2021-2025 | Keytruda, Keytruda Qlex |
Show all 44 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Bowen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.